Trending

UBS picks 2 pharma stocks that are likely to give 23-26% return

Image

​​Ascribing sell ratings to Lupin, Dr Reddy’s Laboratories, Zydus Lifesciences and Aurobindo Pharma, the brokerage said the US generic market has been declining and the pace could worsen.

You Might Also Like...

Sign Up for Our Newsletter

Subscribe now to get notified about exclusive offers
from The .... every week!